2017
DOI: 10.1016/j.prp.2017.07.005
|View full text |Cite
|
Sign up to set email alerts
|

Thymosin beta-4 overexpression correlates with high-risk groups in gastric gastrointestinal stromal tumors: A retrospective analysis by immunohistochemistry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 47 publications
0
2
0
Order By: Relevance
“…Studies have shown that thymosin beta-4 promotes tumor metastasis and is highly expressed in pancreatic cancer, esophageal cancer, colon cancer, and gastric cancer [34][35][36][37]. A study by Sahin et al [38] also showed that thymosin beta-4 was overexpressed in the gastric mucosa of patients with gastrointestinal stromal tumors (GISTs). Overexpression of thymosin beta-4 in the gastric mucosa was related to tumor progression and poor prognosis in the GIST patients.…”
Section: Discussionmentioning
confidence: 99%
“…Studies have shown that thymosin beta-4 promotes tumor metastasis and is highly expressed in pancreatic cancer, esophageal cancer, colon cancer, and gastric cancer [34][35][36][37]. A study by Sahin et al [38] also showed that thymosin beta-4 was overexpressed in the gastric mucosa of patients with gastrointestinal stromal tumors (GISTs). Overexpression of thymosin beta-4 in the gastric mucosa was related to tumor progression and poor prognosis in the GIST patients.…”
Section: Discussionmentioning
confidence: 99%
“…In gliomas, expression of Tβ4 was positively correlated with the tumor grade and silencing Tβ4 inhibited invasion, migration, and enhanced survival of mice by regulating the transforming growth factor beta (TGFβ) and p53 signaling networks [42]. Gastrointestinal stromal tumors showed increased expression of Tβ4 and vascular endothelial growth factor (VEGF), suggesting an aggressive tumor behavior [43]. In breast cancer, overexpression of Tβ4 was strongly associated with expression of HIF-1α, HIF-2α, and VEGF-A [44].…”
Section: Thymosin β4 In Cancermentioning
confidence: 99%